Three family-run businesses to buy now
Family-owned and run businesses really come into their own after sharp sell-offs, says professional investor Adam Johnson of Pictet Asset Management. Here he picks three of his favourites to buy now.
The real value of families becomes apparent in a crisis. The same applies to family-owned and run businesses. Our analysis shows that while they do well over the long term – between 2007 and June 2020 they outperformed the MSCI All Country World index by 56% – they really come into their own after sharp sell-offs, such as the one triggered by Covid-19 this spring.
Research shows that family firms are not only more profitable, but also outperform non-family owned companies. The source of this resilience is an emphasis on quality, growth and profitability. These firms tend to have lower leverage and consequently stronger balance sheets, something investors welcome during turbulent times.
A leader in luxury goods
These strengths reflect family owners’ priorities. First-generation companies tend to retain the founder’s drive, entrepreneurial spirit and ambition. But there is also a deep sense of stewardship from the first generation onward.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
This encourages a long-term approach. Of course, there are potential pitfalls too, not least risks to corporate governance that can be posed by a dominant shareholder.
We evaluate companies’ governance according to our customised metrics. A particularly high-scoring company, and one we invest in, is Hermès (Paris: RMS), the luxury goods firm. Hermès’s long-term vision and identity is fiercely protected by the family.
The focus is on quality, maintaining iconic status and resisting quick wins. The result is a stable, very profitable industry-leading company with plenty of cash to tide it over through crises such as the Covid-19 pandemic.
Delivering food with driverless cars
Roughly half of the firms we invest in have been family-held for several generations. The other half are still managed by their founders. One of these is our fifth-largest holding, Meituan-Dianping (Hong Kong: 3690), a leading Chinese online-shopping and services platform.
Co-founder and major shareholder Wang Xing has impressed analysts with his entrepreneurial drive. He has a particular gift for identifying new niches and disrupting existing businesses.
He demonstrated it during the height of the Covid-19 crisis and lockdown, when he managed to maintain grocery deliveries in Beijing by introducing an unmanned service in which driverless vehicles brought people their orders.
A second-generation winner
Another company in our top ten is CGI (Toronto: GIB.A), one of the world’s largest IT and business-consulting services firms. Catering to both commercial and government clients, it is now in its second generation of family ownership. One of CGI’s key successes has been integrating acquisitions, thanks to its commitment to capturing the loyalty of its employees.
Our portfolio is very different from standard global-equity indices. North American companies comprise less than 40%, with about as much in European investments. We hold between 40 and 60 companies. Our stocks are cash-rich and boast higher returns on equity, a key gauge of profitability, than the market average. And though we pay a premium based on price/earnings ratios, the valuations look very attractive once their growth potential is factored in.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Adam Johnson is a product specialist at Pictet Asset Management's Pictet Family.
-
Trump’s tariffs: what is he thinking and how should UK respond?
Every right-thinking person knows that free trade is a surer route to the wealth of nations than protectionism, says Stuart Watkins. What is Trump thinking?
By Stuart Watkins Published
-
Barclays begins paying up to £100 compensation to customers after banking outage
Barclays will pay up to £7.5 million in compensation to customers after its banking services were disrupted by an IT outage
By Daniel Hilton Published
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published